Company intelligence / Profile preview
Universe Pharmaceuticals INC
Ji'An, Jiangxi, Chinauniverse-pharmacy.com ↗
- Ownership
- Public · UPC
- Employees
- ~225
- Development stage
- Other
01
Overview
The company has registered and obtained approval for 26 varieties of TCMD products from the National Medical Products Administration (NMPA) and currently produces 13 varieties of TCMD products[1]. Six of their products were included in the First Edition of Catalogue of Medicine for Patients Infected with COVID-19, published by Beijing Health Commission on December 12, 2022[9].
- Therapeutic areas
- PulmonologyNephrologyRheumatologyOtherInfectious Diseases
- Modalities
- Traditional Chinese medicine derivatives (TCMD)biomedical drugs
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Financials
- Market cap
- $884.5K
- Total revenue
- $17.9M
- Enterprise value
- $-18.6M
Beyond the preview
Go deeper on Universe Pharmaceuticals INC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Universe Pharmaceuticals INC.